Explore how AI-driven approaches enhance high-throughput screening by optimizing DNA-encoded libraries (DEL) for rapid identification of potential drug candidates.
Learn how AI algorithms accelerate the analysis of complex screening data, enabling more efficient lead discovery and targeting of molecular interactions.
Speaker(s):
Hans Bitter
Head, Computational Sciences
Takeda
Jason Cross
Institute Director, Structural & Computational Drug Design
MD Anderson Cancer Center
Time:
11:45 AM - 12:15 PM
Agenda Track No.:
Track 2
Session Type:
General Session (Presentation)